Recent Synthetic Approaches towards Small Molecule Reactivators of p53.

作者: Jerson L. Silva , Carolina G. S. Lima , Luciana P. Rangel , Giulia D. S. Ferretti , Fernanda P. Pauli

DOI: 10.3390/BIOM10040635

关键词: Cell cycleMdm2Function (biology)SuppressorSense (molecular biology)Cancer researchSmall moleculeMutantGeneBiology

摘要: The tumor suppressor protein p53 is often called "the genome guardian" and controls the cell cycle integrity of DNA, as well other important cellular functions. Its main function to trigger process apoptosis in cells, approximately 50% all cancers are related inactivation through mutations TP53 gene. Due association mutant with cancer therapy resistance, different forms restoration have been subject intense research recent years. In this sense, review focus on currently adopted approaches for activation reactivation function, focusing synthetic that involved development preparation such small molecules.

参考文章(189)
Kensuke Kojima, Steven M. Kornblau, Vivian Ruvolo, Archana Dilip, Seshagiri Duvvuri, R. Eric Davis, Min Zhang, Zhiqiang Wang, Kevin R. Coombes, Nianxiang Zhang, Yi Hua Qiu, Jared K. Burks, Hagop Kantarjian, Sharon Shacham, Michael Kauffman, Michael Andreeff, Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood. ,vol. 121, pp. 4166- 4174 ,(2012) , 10.1182/BLOOD-2012-08-447581
Yili Yang, Robert L. Ludwig, Jane P. Jensen, Shervon A. Pierre, Maxine V. Medaglia, Ilia V. Davydov, Yassamin J. Safiran, Pankaj Oberoi, John H. Kenten, Andrew C. Phillips, Allan M. Weissman, Karen H. Vousden, Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells Cancer Cell. ,vol. 7, pp. 547- 559 ,(2005) , 10.1016/J.CCR.2005.04.029
Klaus Michelsen, John B. Jordan, Jeffrey Lewis, Alexander M. Long, Evelyn Yang, Yosup Rew, Jing Zhou, Peter Yakowec, Paul D. Schnier, Xin Huang, Leszek Poppe, Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors Journal of the American Chemical Society. ,vol. 134, pp. 17059- 17067 ,(2012) , 10.1021/JA305839B
Jerson L. Silva, Claudia V. De Moura Gallo, Danielly C.F. Costa, Luciana P. Rangel, Prion-like aggregation of mutant p53 in cancer Trends in Biochemical Sciences. ,vol. 39, pp. 260- 267 ,(2014) , 10.1016/J.TIBS.2014.04.001
D. P. Lane, p53, guardian of the genome Nature. ,vol. 358, pp. 15- 16 ,(1992) , 10.1038/358015A0
Hari Babu Mereyala, Maju Joe, Cytotoxic activity of styryl lactones and their derivatives. Current Medicinal Chemistry - Anti-cancer Agents. ,vol. 1, pp. 293- 300 ,(2001) , 10.2174/1568011013354606
Jianyuan Luo, Anatoly Y. Nikolaev, Shin-ichiro Imai, Delin Chen, Fei Su, Ariel Shiloh, Leonard Guarente, Wei Gu, Negative Control of p53 by Sir2α Promotes Cell Survival under Stress Cell. ,vol. 107, pp. 137- 148 ,(2001) , 10.1016/S0092-8674(01)00524-4
J Wischhusen, U Naumann, H Ohgaki, F Rastinejad, M Weller, CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death Oncogene. ,vol. 22, pp. 8233- 8245 ,(2003) , 10.1038/SJ.ONC.1207198
Shanghai Yu, Dongguang Qin, Sanjeev Shangary, Jianyong Chen, Guoping Wang, Ke Ding, Donna McEachern, Su Qiu, Zaneta Nikolovska-Coleska, Rebecca Miller, Sanmao Kang, Dajun Yang, Shaomeng Wang, Potent and Orally Active Small-Molecule Inhibitors of the MDM2−p53 Interaction Journal of Medicinal Chemistry. ,vol. 52, pp. 7970- 7973 ,(2009) , 10.1021/JM901400Z
Nicole Zache, Jeremy M.R. Lambert, Nina Rökaeus, Jinfeng Shen, Pierre Hainaut, Jan Bergman, Klas G. Wiman, Vladimir J.N. Bykov, Mutant p53 targeting by the low molecular weight compound STIMA-1. Molecular Oncology. ,vol. 2, pp. 70- 80 ,(2008) , 10.1016/J.MOLONC.2008.02.004